Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors
Abroad (travel likely)RecruitingPHASE2
Conditions
Progression-free Survival · Gastrointestinal Stromal Tumor · Neoadjuvant
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Contact: Study coordinator (Jiren Yu)
Study leads
Jiren Yu
Principal Investigator
Zhejiang University